Co-variation of glutathione transferase expression and cytostatic drug resistance in HeLa cells: establishment of class Mu glutathione transferase M3-3 as the dominating isoenzyme
- PMID: 8280111
- PMCID: PMC1137790
- DOI: 10.1042/bj2970059
Co-variation of glutathione transferase expression and cytostatic drug resistance in HeLa cells: establishment of class Mu glutathione transferase M3-3 as the dominating isoenzyme
Abstract
Qualitative and quantitative analyses of glutathione, glutathione transferases (GSTs) and other glutathione-linked enzymes in HeLa cells have been made in order to study their significance in cellular resistance to electrophilic cytotoxic agents. The cytosolic concentrations of three GSTs, GST M1-1 (53 +/- 9 ng/mg of cytosolic protein), GST P1-1 (11 +/- 3 ng/mg) and GST A1-1 (1.1 +/- 0.4 ng/mg) were quantified by isoenzyme-specific enzyme-linked immunoassays. Electrophoretic analysis and immunoblotting demonstrated another component, GST M3-3, which was identified by amino acid sequence analysis. GST M3-3 was quantified (1550 +/- 250 ng/mg) by slot-blot immunoanalysis and was the most abundant GST in HeLa cells. An additional cytosolic 13 kDa protein with high affinity for immobilized glutathione or S-hexyglutathione was found to be identical with a macrophage migration-inhibitory factor, previously identified as a lymphokine. Cells grown in roller bottles (HR) rather than in ordinary culture flasks contain a significantly lower concentration of all the GSTs and were found to be more sensitive to the cytostatic agents doxorubicin (2.3-fold), cisplatin (1.7-fold) and melphalan (1.4-fold). The cytosolic concentrations of glutathione reductase and glyoxalase I were also lower in HR cells, whereas the total glutathione concentration was unchanged and the glutathione peroxidase activity was increased. The results indicate that GSTs contribute to the cellular resistance phenotype.
Similar articles
-
Acquired resistance to cisplatin and doxorubicin in a small cell lung cancer cell line is correlated to elevated expression of glutathione-linked detoxification enzymes.Carcinogenesis. 1994 Jun;15(6):1167-73. doi: 10.1093/carcin/15.6.1167. Carcinogenesis. 1994. PMID: 8020151
-
A comparison of the enzymatic and physicochemical properties of human glutathione transferase M4-4 and three other human Mu class enzymes.Arch Biochem Biophys. 1994 Jun;311(2):487-95. doi: 10.1006/abbi.1994.1266. Arch Biochem Biophys. 1994. PMID: 8203914
-
Microsomal glutathione S-transferase A1-1 with glutathione peroxidase activity from sheep liver: molecular cloning, expression and characterization.Biochem J. 2001 Dec 1;360(Pt 2):345-54. doi: 10.1042/0264-6021:3600345. Biochem J. 2001. PMID: 11716762 Free PMC article.
-
The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.Crit Rev Biochem Mol Biol. 1995;30(6):445-600. doi: 10.3109/10409239509083491. Crit Rev Biochem Mol Biol. 1995. PMID: 8770536 Review.
-
Mammalian cytosolic glutathione transferases.Curr Protein Pept Sci. 2008 Aug;9(4):325-37. doi: 10.2174/138920308785132677. Curr Protein Pept Sci. 2008. PMID: 18691123 Review.
Cited by
-
Delta 3, delta 2-enoyl-CoA isomerase is the protein that copurifies with human glutathione S-transferases from S-hexylglutathione affinity matrices.Biochem J. 1994 Dec 15;304 ( Pt 3)(Pt 3):849-52. doi: 10.1042/bj3040849. Biochem J. 1994. PMID: 7818490 Free PMC article.
-
Variability of glutathione S-transferase isoenzyme patterns in matched normal and cancer human breast tissue.Biochem J. 1994 Dec 15;304 ( Pt 3)(Pt 3):843-8. doi: 10.1042/bj3040843. Biochem J. 1994. PMID: 7818489 Free PMC article.
-
An Introspective Update on the Influence of miRNAs in Breast Carcinoma and Neuroblastoma Chemoresistance.Genet Res Int. 2014;2014:743050. doi: 10.1155/2014/743050. Epub 2014 Dec 4. Genet Res Int. 2014. PMID: 25548681 Free PMC article. Review.
-
Construction of a model cell line for the assay of MDR1 (multi drug resistance gene-1) substrates/inhibitors using HeLa cells.Pharmazie. 2009 May;64(5):296-300. Pharmazie. 2009. PMID: 19530439 Free PMC article.
-
Mechanisms of drug resistance in colon cancer and its therapeutic strategies.World J Gastroenterol. 2016 Aug 14;22(30):6876-89. doi: 10.3748/wjg.v22.i30.6876. World J Gastroenterol. 2016. PMID: 27570424 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials